ARVN
ARVINAS, INC.
NASDAQ · Healthcare · Biotechnology · US
$8.29
−0.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- 43.63x
- PEG TTM
- —
- Price / book
- 0.96x
- Price / sales
- 1.71x
- Price / cash flow
- -2.62x
Enterprise value
- Enterprise value
- -$17.6M
- EV / sales
- -0.06x
- EV / EBITDA
- -6.09x
- EV / EBIT
- 1.25x
- Market cap
- $542.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026